Drug profile · INN
ivosidenib
TIBSOVO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ivosidenib (TIBSOVO) is an FDA-listed pharmaceutical active ingredient. Associated with Agios Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ivosidenib
Brand TIBSOVO
Route ORAL
Formulation TABLET
ATC code L01XM02
Originator Agios Netherlands B.V.
Frequently asked questions
What is ivosidenib?
ivosidenib (TIBSOVO) is an FDA-listed pharmaceutical active ingredient. Associated with Agios Netherlands B.V.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ivosidenib?
TIBSOVO is a marketed brand name for ivosidenib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ivosidenib?
ivosidenib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.